Skip to main content

Table 1 Patient characteristics

From: A novel predictive factor for the onset time of docetaxel-induced onychopathy: a multicenter retrospective study

Characteristics Value (n = 95)
Age (mean years ± S.D.) 62.1 ± 12.0
Gender (n, male/female) 54/41
Body surface area (m2, mean ± S.D.) 1.57 ± 0.17
Concomitant use of 5-FU drugsa) (n, Y/N) 33/62
Hemoglobin at the start of administration (mean g/dL ± S.D.) 11.2 ± 1.8
Primary site
Stomach, n (%) 32 (33.7)
Breast, n (%) 23 (24.2)
Lung, n (%) 19 (20.0)
Prostatic, n (%) 9 (9.5)
Others, n (%) 12 (12.6)
  1. a)5-FU drugs: 5-fluorouracil, capecitabine, tegafur/gimeracil/oteracil